Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
复制标题
DOI:
10.1016/j.xcrm.2023.101148
复制
发表时间:
2023-08-15
影响因子:
14.3
通讯作者:
Bettegowda, Chetan
中科院分区:
文献类型:
--
作者:
Douville, Christopher;Curtis, Samuel;Summers, Mahmoud;Azad, Tej D.;Rincon-Torroella, Jordina;Wang, Yuxuan;Mattox, Austin;Avigdor, Bracha;Dudley, Jonathan;Materi, Joshua;Raj, Divyaansh;Nair, Sumil;Bhanja, Debarati;Tuohy, Kyle;Dobbyn, Lisa;Popoli, Maria;Ptak, Janine;Nehme, Nadine;Silliman, Natalie;Blair, Cherie;Judge, Kathy;Gallia, Gary L.;Groves, Mari;Jackson, Christopher M.;Jackson, Eric M.;Laterra, John;Lim, Michael;Mukherjee, Debraj;Weingart, Jon;Naidoo, Jarushka;Koschmann, Carl;Smith, Natalya;Schreck, Karisa C.;Pardo, Carlos A.;Glantz, Michael;Holdhoff, Matthias;Kinzler, Kenneth W.;Papadopoulos, Nickolas;Vogelstein, Bert;Bettegowda, Chetan
It is often challenging to distinguish cancerous from non-cancerous lesions in the brain using conventional diagnostic approaches. We introduce an analytic technique called Real-CSF (repetitive element aneuploidy sequencing in CSF) to detect cancers of the central nervous system from evaluation of DNA in the cerebrospinal fluid (CSF). Short interspersed nuclear elements (SINEs) are PCR amplified with a single primer pair, and the PCR products are evaluated by next-generation sequencing. Real-CSF assesses genome-wide copy-number alterations as well as focal amplifications of selected oncogenes. Real-CSF was applied to 280 CSF samples and correctly identified 67% of 184 cancerous and 96% of 96 non-cancerous brain lesions. CSF analysis was considerably more sensitive than standard-of-care cytology and plasma cell-free DNA analysis in the same patients. Real-CSF therefore has the capacity to be used in combination with other clinical, radiologic, and laboratory-based data to inform the diagnosis and management of patients with suspected cancers of the brain. Limited DNA in the cerebrospinal fluid (CSF) poses challenges for genetic techniques Copy-number alterations are a feature of nearly all CNS cancers Real-CSF works in limited starting material and identifies copy-number alterations Real-CSF can detect neoplasia in CSF across a heterogeneous set of CNS cancers Douville et al. introduce Real-CSF—a molecular technique designed to identify copy-number alterations spread throughout the genome from limited starting material in cerebrospinal fluid. Even though central nervous system cancers comprise a heterogeneous set of tumors, nearly all will contain copy-number alterations, making this a putative multi-cancer biomarker.
登录
查看更多内容
DOI:
10.1016/j.annonc.2020.02.011
发表时间:
2020-06
期刊:
Annals of oncology : official journal of the European Society for Medical Oncology
影响因子:
--
作者:
Liu MC;Oxnard GR;Klein EA;Swanton C;Seiden MV;CCGA Consortium
通讯作者:
CCGA Consortium
影响因子:
16.6
作者:
De Mattos-Arruda L;Mayor R;Ng CKY;Weigelt B;Martínez-Ricarte F;Torrejon D;Oliveira M;Arias A;Raventos C;Tang J;Guerini-Rocco E;Martínez-Sáez E;Lois S;Marín O;de la Cruz X;Piscuoglio S;Towers R;Vivancos A;Peg V;Ramon y Cajal S;Carles J;Rodon J;González-Cao M;Tabernero J;Felip E;Sahuquillo J;Berger MF;Cortes J;Reis-Filho JS;Seoane J
通讯作者:
Seoane J
影响因子:
2.8
作者:
Abbasi AW;Westerlaan HE;Holtman GA;Aden KM;van Laar PJ;van der Hoorn A
通讯作者:
van der Hoorn A
影响因子:
2.8
作者:
Pasternak KA;Schwake M;Warneke N;Masthoff M;Zawy Alsofy S;Suero Molina E;Stummer W;Schipmann S
通讯作者:
Schipmann S
影响因子:
5.6
作者:
Bockaj, Irena;Martini, Tosca E., I;Smit, Marlinde J.;Armandari, Inna;Bakker, Bjorn;Wardenaar, Rene;Meeuwsen-de Boer, Tiny G. J.;Bakker, Petra L.;Spierings, Diana C. J.;Hoving, Eelco W.;Guryev, Victor;Foijer, Floris;Bruggeman, Sophia W. M.
通讯作者:
Bruggeman, Sophia W. M.